ITGA2B and myocardial infarction: Oral GP IIb/IIIa antagonists used in the setting of acute myocardial infarction have generally been disappointing, and a meta-analysis suggested a higher mortality for ESRD patients treated with clopidogrel and/or aspirin [43].